Inhaled corticosteroids reduce airway inflammation and bronchial hyper-responsiveness in asthma. Their regular use is associated with a reduction in morbidity and mortality from asthma. International guidelines recommend their use as first-line treatment in asthma and the dose should be increased stepwise in accordance with asthma severity Short-acting Pz-agonists are recommended for use as reliever medication for the acute relief of symptoms. Long-acting b2-agonists have a sustained bronchodilator action but are not recommended for use as monotherapy in asthma, particularly because they laclc clinically relevant anti-inflammatory action.The seminal observation in a controlled trial that the addition of salmeterol to low-dose inhaled beclomethasone dipropionate was superior to doubling the dose ofthe beclomethasone dipropionate was followed by several well-controlled studies that confirmed this observationThese included multinational and multicentre trials in large numbers of patients and the use of different inhaled corticosteroids and the two long-acting Pl-agonists, formoterol and salmeterol. 
EFFICACY OF BUDESONIDE AND FORMOTEROL

SYMBICORT@ CONTROLLING ASTHMA IN ADULTS
Symbicort @ Turbuhaler @ is a dry powder inhaler containing both budesonide and formoterol.
Here we report the efficacy and safety of Symbicort@ in two l2-week, multicentre, multinational, double-blind studies involving over 800 patients (30, 31 Table I ). All patients had experienced asthma for at least I2 years, had a low number of symptom-free days and the mean FEV, was on average 73-82% of the predicted normal, with approximately 22% reversibility.
Lung function was assessed in terms of peak expiratory flow (PEF), FEVr and forced vital capacity (FVC) as an objective measure of treatment efficacy. Other outcome measures included use of reliever medication, total asthma symptom scores, nocturnal awakenings, symptom-free days and asthma-control days. Chdnge in use of reliever medication was also assesse<:.
Symbicort@ is significantly more effective than budesonide alone Symbicort@ is as effective as budesonide plus formoterol administered separately 
